US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 7.600
  • +0.110+1.47%
Close Dec 26 16:00 ET
  • 7.590
  • -0.010-0.13%
Post 16:14 ET
2.32BMarket Cap-5.14P/E (TTM)

Iovance Biotherapeutics Key Stats

Iovance Biotherapeutics Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
53.82M
58.56M
+4.74M
Beat Est.
+11375.09%
+12385.07%
+8.80%
EPS
-0.30
-0.28
+0.02
Beat Est.
+35.23%
+39.13%
+6.01%
Strong Buy

Dec 12, 2024

Iovance Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 88.588M--
--2024/Q4-- / 71.570M--
Nov 7, 20242024/Q358.555M / 53.818M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 88.588M--
--2024/Q4-- / 71.570M--
Nov 7, 20242024/Q358.555M / 53.818M--
Aug 8, 20242024/Q231.106M / 24.561M--
May 9, 20242024/Q1715.000K / 2.088M--

Unlock Free Earnings Estimates

Iovance Biotherapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 12, 2024

Strong Buy

  • Buy

    88.89%
  • Hold

    11.11%
  • Sell

    0.00%

Price Target

No Data